Premier Path Wealth Partners’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $92.2K | Hold |
10,000
| – | – | 0.01% | 386 |
|
|
2025
Q1 | $85.8K | Sell |
10,000
-2,500
| -20% | -$21.5K | 0.01% | 371 |
|
|
2024
Q4 | $134K | Hold |
12,500
| – | – | 0.02% | 368 |
|
|
2024
Q3 | $71K | Hold |
12,500
| – | – | 0.01% | 363 |
|
|
2024
Q2 | $52.8K | Hold |
12,500
| – | – | 0.01% | 367 |
|
|
2024
Q1 | $63.6K | Hold |
12,500
| – | – | 0.01% | 342 |
|
|
2023
Q4 | $116K | Buy |
+12,500
| New | +$116K | 0.03% | 331 |
|